Spring Step Yared Slip On Ballerina Women's OjmrBdjqH

SKU82643231
Spring Step Yared Slip On Ballerina (Women's) OjmrBdjqH
Spring Step Yared Slip On Ballerina (Women's)
AT Internet
Skip to main content
Education and training
Supporting education and training in Europe and beyond
Steve Madden Lover LaceUp Back Tall Boot fpqT2GFful
> Pleaser Aspire 609MMG Platform Sandal Womens uyywdK
> Education and training
European Universities Initiative
Policies

Policies

Stay
Initiatives
Stay
Updates
Stay
Resources
Stay

/education/file/shutterstock245381353-resizedjpg_enshutterstock_245381353-resized.jpg

© Shutterstock

At the 2017 Gothenburg Summit,EU leaders outlined a vision for increasing policy attention in Europe to education and culture. In its December 2017 Conclusions

Merrell Solo Hiking Shoe Womens TLaQA3s

'…strengthening strategic partnerships across the EU between higher education institutions and encouraging the emergence by 2024 of some twenty 'European Universities', consisting in bottom-up networks of universities across the EU which will enable students to obtain a degree by combining studies in several EU countries and contribute to the international competitiveness of European universities'.

The aim behind this initiative is to bring together a new generation of creative Europeans, who are able to cooperate in different languages, across borders and disciplines, to address the big societal challenges and skills shortages that Europe faces.

This initiative must be a game changer in higher education. Building on excellent examples such as Erasmus Mundus, Marie Skłodowska-Curie Actions and the European Institute of Innovation Technology, Europe must make a leap forward. Driven by high quality, these European Universities would attract the best students, teachers and researchers, making use of the most innovative pedagogies and digital technologies. They would act as role models for other higher education institutions, progressively increasing the international competitiveness of European higher education.

During the Education Council of 15 February, Ministers showed support for the initiative, noting that it should be aiming at quality and excellence while at the same time securing geographical balance across the EU and involving universities from all Member States. They underlined the link between education and research as an important principle. They also emphasisedthat the initiative needs to be ambitious enough to foster a new positive spirit of collaboration between universities in Europe.

The European Commission is currently consulting stakeholders at all levels, from grassroots practitioners of well-advanced transnational cooperation to ministries in Member States, in order to co-create the full concept of this initiative. As part of this joint effort, the European Commission is making publicly available the concept papers that are being received. Any additional contributions can be sent to Genuine Grip Footwear SlipResistant Waterproof Boot Womens I1toeEpJ

Glossary

Study record managers: refer to the Dearfoams Felt XStitch Clog Womens DJojJ4
if submitting registration or results information.

A type of eligibility criteria that indicates whether people who do not have the condition/disease being studied can participate in that clinical study.
An arm type in which a group of participants receives an intervention/treatment considered to be effective (or active) by health care providers.
An unfavorable change in the health of a participant, including abnormal laboratory findings, that happens during a clinical study or within a certain amount of time after the study has ended. This change may or may not be caused by the intervention/treatment being studied.
A type of eligibility criteria that indicates the age a person must be to participate in a clinical study. This may be indicated by a specific age or the following age groups:

The age groups are:

A method used to assign participants to an arm of a clinical study. The types of allocation are randomized allocation and nonrandomized.
A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment , or no intervention, according to the trial's protocol .
A general description of the clinical trial arm. It identifies the role of the intervention that participants receive. Types of arms include experimental arm , active comparator arm , placebo comparator arm , sham comparator arm , and no intervention arm .
Data collected at the beginning of a clinical study for all participants and for each arm or comparison group. These data include demographics, such as age, sex/gender, race and ethnicity, and study-specific measures (for example, systolic blood pressure, prior antidepressant treatment).
Indicates that the study sponsor or investigator recalled a submission of study results before quality control (QC) review took place. If the submission was canceled on or after May 8, 2018, the date is shown. After submission of study results, a study record cannot be modified until QC review is completed, unless the submission is canceled.
Information required by the Food and Drug Administration Amendments Act of 2007 . In general, this is a description of any agreement between the sponsor of a clinical study and the principal investigator (PI) that does not allow the PI to discuss the results of the study or publish the study results in a scientific or academic journal after the study is completed.
A sponsor or investigator may submit a certification to delay submission of results information if they are applying for FDA approval of a new drug or device, or new use of an already approved drug or device. A sponsor or investigator who submits a certification can delay results submission up to 2 years after the certification/extension first submitted date, unless certain events occur sooner. See SKECHERSModa Lady Pink EUBIYN
in the Results Data Element definitions for more information about this certification.
The date on which information about a certification to delay submission of results or an extension request was first available on ClinicalTrials.gov. ClinicalTrials.gov does not indicate whether the submission was a certification or extension request. There is typically a delay between the date the study sponsor or investigator submitted the certification or extension request and the first posted date .
The date on which the study sponsor or investigator first submitted a certification or an extension request to delay submission of results. A sponsor or investigator who submits a certification can delay results submission up to 2 years after this date, unless certain events occur sooner. There is typically a delay between the date the certification or extension request was submitted and the date the information is first available on ClinicalTrials.gov ( certification/extension first posted ).
The date on which the study sponsor or investigator first submitted a certification or an extension request that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a certification or extension request one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria. Meeting QC criteria for an extension request does not mean that the National Institutes of Health (NIH) has determined that the request demonstrates good cause. The process for review and granting of extension requests by the NIH is being developed.
In the search feature, the City field is used to find clinical studies with locations in a specific city. The Distance field is used to find studies with locations within the specified distance from a city in number of miles. For example, if you choose Illinois as the state , identifying "Chicago" as the city and "100 miles" as the distance will find all studies listing a location within 100 miles of Chicago.
A research study involving human volunteers (also called participants) that is intended to add to medical knowledge. There are two types of clinical studies: interventional studies (also called clinical trials) and observational studies .
Another name for an interventional study .
The unique identification code given to each clinical study upon registration at ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419).
An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.
The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.
In the search feature, the Country field is used to find clinical studies with locations in a specific country. For example, if you choose the United States, you can then narrow your search by selecting a state and identifying a city and distance .
A type of intervention model describing a clinical trial in which groups of participants receive two or more interventions in a specific order. For example, two-by-two cross-over assignment involves two groups of participants. One group receives drug A during the initial phase of the trial, followed by drug B during a later phase. The other group receives drug B during the initial phase, followed by drug A. So during the trial, participants "cross over" to the other drug. All participants receive drug A and drug B at some point during the trial but in a different order, depending on the group to which they are assigned.
A group of independent scientists who monitor the safety and scientific integrity of a clinical trial . The DMC can recommend to the sponsor that the trial be stopped if it is not effective, is harming participants, or is unlikely to serve its scientific purpose. Members are chosen based on the scientific skills and knowledge needed to monitor the particular trial. Also called a data safety and monitoring board, or DSMB.
A phase of research used to describe exploratory trials conducted before traditional phase 1 trials to investigate how or whether a drug affects the body. They involve very limited human exposure to the drug and have no therapeutic or diagnostic goals (for example, screening studies, microdose studies).
The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers , has age or age group requirements, or is limited by sex .
The number of participants in a clinical study. The "estimated" enrollment is the target number of participants that the researchers need for the study.
A type of eligibility criteria . These are reasons that a person is not allowed to participate in a clinical study.
A way for patients with serious diseases or conditions who cannot participate in a clinical trial to gain access to a medical product that has not been approved by the U.S. Food and Drug Administration (FDA) . Also called compassionate use. There are different expanded access types .

For more information, see FDA Crocs Neria Pro II Closed Back Clog Womens yxcwu
.

Available:

102.9 THE HOG Copyright 2018 Saga Communications, Inc. All rights reserved. EEO Report | FCC Public File | For assistance accessing public files, contact FitFlopLido Slide Sandals yWUid
Privacy Policy | Terms of Use | Dr Scholls Friendly Ballet Flat Womens TpqEgsl3o0
| Wild Diva Lounge Farrah Slide Sandal VXJguBY
| Some images copyright AP, Clipart.com, Reuters, WENN Non-Discriminatory Advertising Letter | Advisory Public Notice - Non-Discriminatory Ad Contracts